Bioinformatics analysis of SARS-Cov M protein provides information for vaccine development

被引:0
|
作者
LIU Wanli
Protein Science Laboratory of MOE
机构
关键词
SARS-Cov; M protein; anti-SARS vaccine strategy;
D O I
暂无
中图分类号
R373 [人体病毒学(致病病毒)];
学科分类号
100103 ; 100705 ;
摘要
The pathogen causing severe acute respiratory syndrome (SARS) is identified to be SARS-Cov. It is urgent to know more about SARS-Cov for developing an efficient SARS vaccine to prevent this epidemic disease. In this report, the homology of SARS-Cov M protein to other members of coronavirus is illustrated, and all amino acid changes in both S and M proteins among all available SARS-Cov isolates in GenBank are described. Furthermore, one topological trans-membrane secondary structure model of M protein is proposed, which is corresponded well with the accepted topology model of M proteins of other members of coronavirus. Hydrophilic profile analysis indicated that one region (aa150~210) on the cytoplasmic domain is fairly hydrophilic, suggesting its property of antigenicity. Based on the fact that cytoplasmic domain of the M protein of some other coronavirus could induce protective activities against virus infection, this region might be one potential target for SARS vaccine development.
引用
收藏
页码:44 / 47
页数:4
相关论文
共 50 条
  • [1] Bioinformatics analysis of SARS-Cov M protein provides information for vaccine development
    Liu, WL
    Lu, Y
    Chen, YH
    PROGRESS IN NATURAL SCIENCE-MATERIALS INTERNATIONAL, 2003, 13 (11) : 844 - 847
  • [2] The spike protein of SARS-CoV — a target for vaccine and therapeutic development
    Lanying Du
    Yuxian He
    Yusen Zhou
    Shuwen Liu
    Bo-Jian Zheng
    Shibo Jiang
    Nature Reviews Microbiology, 2009, 7 : 226 - 236
  • [3] The spike protein of SARS-CoV - a target for vaccine and therapeutic development
    Du, Lanying
    He, Yuxian
    Zhou, Yusen
    Liu, Shuwen
    Zheng, Bo-Jian
    Jiang, Shibo
    NATURE REVIEWS MICROBIOLOGY, 2009, 7 (03) : 226 - 236
  • [4] Phylogenomics and bioinformatics of SARS-CoV
    Liò, P
    Goldman, N
    TRENDS IN MICROBIOLOGY, 2004, 12 (03) : 106 - 111
  • [5] SARS-CoV Genome Polymorphism: A Bioinformatics Study
    Gordana M. Pavlovi-La■eti
    Nenad S. Miti
    Andrija M. Tomovi
    Mirjana D. Pavlovi
    Milo V.Beljanski
    Genomics Proteomics & Bioinformatics, 2005, (01) : 26 - 43
  • [6] Expression and membrane integration of SARS-CoV M protein
    Ma, Hsin-Chieh
    Fang, Chiu-Ping
    Hsieh, Yi-Ching
    Chen, Shih-Chi
    Li, Hui-Chun
    Lo, Shih-Yen
    JOURNAL OF BIOMEDICAL SCIENCE, 2008, 15 (03) : 301 - 310
  • [7] Effects of the Addition of Hiltonol® (Poly-ICLC) to a SARS-CoV S Protein Vaccine in Lethal SARS-CoV Mouse Model
    Barnard, Dale L.
    Wandersee, Miles
    Bailey, Kevin
    Smith, Aaron
    Vest, Zach
    Morrey, John D.
    Salazar, Andres M.
    ANTIVIRAL RESEARCH, 2011, 90 (02) : A28 - A28
  • [8] The M Protein of SARS-CoV: Basic Structural and Immunological Properties
    Yongwu Hu
    2 James D. Watson Institute of Genome Sciences
    3 College of Life Sciences
    Genomics Proteomics & Bioinformatics, 2003, (02) : 118 - 130
  • [9] SARS-CoV S Protein Induces Strong Mucosal Immune Responses and Provides Long-term Protection Against SARS-CoV Infection
    Zheng, B. J.
    Du, L.
    Zhao, G.
    VACCINE, 2008,
  • [10] Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development
    Oves, Mohammad
    Ravindran, Mithunan
    Rauf, Mohd Ahmar
    Omaish Ansari, Mohammad
    Zahin, Maryam
    Iyer, Arun K.
    Ismail, Iqbal M. I.
    Khan, Meraj A.
    Palaniyar, Nades
    PATHOGENS, 2020, 9 (12): : 1 - 16